The U.S. Food and Drug Administration has cleared for marketing a new safety engineered short-term peripheral Intra-Venous (IV) Catheter. The product, VantageCath, is designed to significantly reduce exposure to bloodborne pathogens during the placement of the catheter and also provide the clinician with desirable feature sets.
Existing safety engineered peripheral IVs have mechanisms to protect the [...]

Continue reading " Advantage Medical Devices Receives FDA Clearance for VantageCath "